Developer docs
API playgroundTry for free, no card

Search company profiles

Panvel

Full company profile

uuid000dk1l

Namestring
Panvel
Legal namestring
Panvel Farmácias
Websiteurl
panvel.com
Company typeenum
Private
Founded yearint
1989
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersSão Paulo, Brazil
HQ citystring
São Paulo
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
retail pharmacy services, pharmaceutical retail, over-the-counter medications, dermocosmetics retail, pharmacy healthcare services
Industry2 codes
1Pharmacy & Health Essentials Delivery
CodeCRAFAFAIPrimaryYes
2Dermocosmetics & Medical-Grade Skincare
CodeCRABAAAFPrimaryNo
NAICS code1 code
  • Pharmacies and Drug Retailers45611
SIC code1 code
  • Retail-Drug Stores And Proprietary Stores5912
Product category
Retail Pharmacy
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Retail Pharmacy Sales
TypeOne Time License
Description

Panvel generates revenue through physical retail pharmacy stores and e-commerce sales of medications (OTC and prescription), dermocosmetics, personal care, beauty products, infant care, wellness products, and health monitors/appliances. The business model combines one-time product sales with subscription-style continuous medication programs (Programa Uso Contínuo) and government-subsidized pharmacy programs (Farmácia Popular).

panvel.com
2Pharmaceutical Services
TypeProfessional Services
Description

Revenue from in-store services including Panvel Clinic consultations, rapid tests, vaccinations, and home care services.

panvel.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales, Technology or R&D
Pricing details4 tiers
1Generic medications starting at R$10 for diabetes treatments
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Generic diabetes medications start under R$10, with prices increasing to R$100+ for branded products like Ozempic, Wegovy, and Mounjaro. Reference medications and specialized diabetes supplies (sensors, insulin pens) command premium pricing.

panvel.com
2Nail polish and beauty products under R$40
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Nail polish (esmalte) products are priced under R$10 (282 items) to R$40 (144 items), with most products in the R$10 range. Premium brands like Colorama may reach R$40-80.

panvel.com
3Farmácia Popular government-subsidized medications
ModelSubscriptionBilling cadenceMonthly
Notes

Panvel participates in Brazil's Farmácia Popular program offering subsidized medications for chronic conditions including diabetes, hypertension, and asthma at reduced or no cost to eligible patients.

panvel.com
4Programa Uso Contínuo (Continuous Use Program)
ModelSubscriptionBilling cadenceMonthly
Notes

Subscription-style program for patients requiring continuous medication, offering convenience and potentially discounted pricing for regular medication refills.

panvel.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 2 records shown
1Panvel Clinic
Description

Healthcare services including vaccination, rapid tests, pharmaceutical services, and home care

panvel.com
+1 more record
Core offering1 text field

Panvel Farmácias operates a multi-state Brazilian retail pharmacy chain selling prescription and OTC medications, dermocosmetics, perfumes, baby and maternity products, daily care items, wellness products, and its own Produtos Panvel private-label line through physical stores and the panvel.com e-commerce platform. The offering is extended by the Panvel Clinic service module providing vaccinations, rapid tests, pharmaceutical consultations and home care, plus the Farmácia Popular government-subsidized program and the subscription-style Programa Uso Contínuo for chronic-condition patients.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Panvel Farmácias is a Brazilian pharmacy chain operating as a unified retail platform combining physical stores and e-commerce. The product portfolio centers on the core medications business supplemented by the Panvel Clinic service module providing healthcare services (home care, rapid tests, pharmaceutical services, vaccines), alongside extensive health and beauty categories including dermocosmetics, perfumes, baby/maternity products, and wellness items. Panvel's own brand (Produtos Panvel) offers private-label alternatives across personal care, beauty, and health categories. Additional programs include Farmácia Popular (government-subsidized medications), continuous use medication programs, and laboratory discount programs.

Product and service5 records
1Panvel Farmácias retail pharmacy (in-store and online)
CategoryRetail Pharmacy
Description

Core retail pharmacy business selling prescription and OTC medications, dermocosmetics, perfumes, baby and maternity products, daily care and wellness items, plus the Produtos Panvel private-label line, via physical stores and panvel.com. Targets individual Brazilian consumers.

2Panvel Clinic healthcare services
CategoryPharmacy Healthcare Services
Description

Professional healthcare services delivered in-store or at home, including vaccinations, rapid diagnostic tests, pharmaceutical consultations and home-based care, targeting individual patients and family caregivers.

3Farmácia Popular subsidized pharmacy program
CategoryGovernment Pharmacy Program
Description

Government-subsidized pharmacy program participation that provides eligible Brazilian consumers reduced-price or free medications for chronic conditions including diabetes, hypertension and asthma through Panvel's stores and digital channels.

4Programa Uso Contínuo (continuous medication program)
CategoryMedication Subscription Program
Description

Subscription-style program offering regular refills for patients on continuous medication, providing convenience and potentially discounted pricing for chronic-condition treatment.

5Produtos Panvel and Panvel Make Up private-label line
CategoryPrivate-Label Consumer Products
Description

Panvel's own-brand product range including hair care, vitamins, flu/cold remedies, gastrointestinal products, bath, facial and body care, monitors, first aid, orthopedics, male care, makeup, nails, maternity, baby care, intimate care, oral hygiene, deodorants, fragrances, gifts, convenience items, and food, sold alongside branded items in-store and online.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Panvel's parent/related group operating pharmaceutical distribution and investor relations. Relevant as the wholesale/distribution backbone behind Panvel Farmácias, illustrating the vertical structure of the Panvel business.

TypeDirect peer
Description

Brazilian pharmacy chain operating a network of physical stores and e-commerce, focusing on affordable medications and health products. Comparable omnichannel model and broad assortment approach to Panvel.

TypeBroad incumbent
Description

Brazil's largest pharmacy chain (Raia + Drogasil banners), operating over 2,800 stores nationwide. Overlaps with Panvel on core retail pharmacy offering but competes at vastly greater scale and geographic reach.

4Nissei
TypeDirect peer
Description

Brazilian pharmacy chain with strong regional presence in Southern Brazil (Paraná, Santa Catarina), directly overlapping Panvel's core geography. Both operate multi-state pharmacy retail with comparable mix of medications, dermocosmetics, and personal care.

TypeDirect peer
Description

Brazilian pharmacy with strong digital presence competing on price-driven pharmacy e-commerce. Comparable product categories to Panvel with emphasis on affordable Rx/OTC delivery, representing the digital threat to Panvel's omnichannel model.

TypeDirect peer
Description

Established pharmacy chain headquartered in Santa Catarina with deep roots across Southern Brazil. Closely comparable in regional focus, physical-store-led model, and broad assortment spanning health, beauty, and personal care.

TypeDirect peer
Description

Legacy Brazilian pharmacy chain operating physical stores and e-commerce platform. Competes with Panvel across prescription, OTC, and beauty categories with comparable horizontal assortment.

TypeBroad incumbent
Description

National Brazilian pharmacy chain with operations across multiple regions. Competes with Panvel in the broad retail pharmacy category but with national scale, private-label depth, and broader geographic footprint.

TypeOthers
Description

Brazilian pharmaceutical manufacturer whose products (including those branded and distributed via Panvel) feature prominently in the Panvel catalog. Ecosystem participant as a key supplier rather than direct retail competitor.

TypeBroad incumbent
Description

Major São Paulo-focused pharmacy chain formed by the merger of Drogaria São Paulo and Drogaria Pacheco. Overlaps directly with Panvel in the São Paulo market and shares the omnichannel retail pharmacy model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Panvel

Retail Pharmacypanvel.com

Panvel firmographics

Firmographics
Name
Panvel
Legal name
Panvel Farmácias
Website
https://panvel.com
Company type
Private
Founded year
1989
Operating status
Operating
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

Panvel industry classification

Industry
Product category
Retail Pharmacy
NAICS
Pharmacies and Drug Retailers (45611)
SIC
Retail-Drug Stores And Proprietary Stores (5912)
akta.pro primary industry
Pharmacy & Health Essentials Delivery (CRAFAFAI)
akta.pro secondary industry
Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

Keywords

  • Retail pharmacy services
  • Pharmaceutical retail
  • Over-the-counter medications
  • Dermocosmetics retail
  • Pharmacy healthcare services

Where Panvel is headquartered

Location

Headquarters

HQ city
São Paulo
HQ country
Brazil
HQ region
Latin America

Offices7 records

Markets served

Panvel business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

  1. Retail Pharmacy Sales: Panvel generates revenue through physical retail pharmacy stores and e-commerce sales of medications (OTC and prescription), dermocosmetics, personal care, beauty products, infant care, wellness products, and health monitors/appliances. The business model combines one-time product sales with subscription-style continuous medication programs (Programa Uso Contínuo) and government-subsidized pharmacy programs (Farmácia Popular).
  2. Pharmaceutical Services: Revenue from in-store services including Panvel Clinic consultations, rapid tests, vaccinations, and home care services.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goGeneric medications starting at R$10 for diabetes treatments
Unit PricingPay-as-you-goNail polish and beauty products under R$40
SubscriptionMonthlyFarmácia Popular government-subsidized medications
SubscriptionMonthlyPrograma Uso Contínuo (Continuous Use Program)

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Panvel product offering

Product offering

Core offering

Panvel Farmácias operates a multi-state Brazilian retail pharmacy chain selling prescription and OTC medications, dermocosmetics, perfumes, baby and maternity products, daily care items, wellness products, and its own Produtos Panvel private-label line through physical stores and the panvel.com e-commerce platform. The offering is extended by the Panvel Clinic service module providing vaccinations, rapid tests, pharmaceutical consultations and home care, plus the Farmácia Popular government-subsidized program and the subscription-style Programa Uso Contínuo for chronic-condition patients.

Product overview

Panvel Farmácias is a Brazilian pharmacy chain operating as a unified retail platform combining physical stores and e-commerce. The product portfolio centers on the core medications business supplemented by the Panvel Clinic service module providing healthcare services (home care, rapid tests, pharmaceutical services, vaccines), alongside extensive health and beauty categories including dermocosmetics, perfumes, baby/maternity products, and wellness items. Panvel's own brand (Produtos Panvel) offers private-label alternatives across personal care, beauty, and health categories. Additional programs include Farmácia Popular (government-subsidized medications), continuous use medication programs, and laboratory discount programs.

Differentiator

Problem solved

Functional benefit

Brands

  • Panvel Clinic: Healthcare services including vaccination, rapid tests, pharmaceutical services, and home care
  • Panvel Make Up

Products and services

  • Panvel Farmácias retail pharmacy (in-store and online) Core retail pharmacy business selling prescription and OTC medications, dermocosmetics, perfumes, baby and maternity products, daily care and wellness items, plus the Produtos Panvel private-label line, via physical stores and panvel.com. Targets individual Brazilian consumers.
  • Panvel Clinic healthcare services Professional healthcare services delivered in-store or at home, including vaccinations, rapid diagnostic tests, pharmaceutical consultations and home-based care, targeting individual patients and family caregivers.
  • Farmácia Popular subsidized pharmacy program Government-subsidized pharmacy program participation that provides eligible Brazilian consumers reduced-price or free medications for chronic conditions including diabetes, hypertension and asthma through Panvel's stores and digital channels.
  • Programa Uso Contínuo (continuous medication program) Subscription-style program offering regular refills for patients on continuous medication, providing convenience and potentially discounted pricing for chronic-condition treatment.
  • Produtos Panvel and Panvel Make Up private-label line Panvel's own-brand product range including hair care, vitamins, flu/cold remedies, gastrointestinal products, bath, facial and body care, monitors, first aid, orthopedics, male care, makeup, nails, maternity, baby care, intimate care, oral hygiene, deodorants, fragrances, gifts, convenience items, and food, sold alongside branded items in-store and online.

Companies that use Panvel

Customer profile

Segments5 records

Ideal customer profiles5 records

Panvel technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Panvel partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Panvel competitors and assessment

Company assessment

Others

  • Grupo Dimed: Panvel's parent/related group operating pharmaceutical distribution and investor relations. Relevant as the wholesale/distribution backbone behind Panvel Farmácias, illustrating the vertical structure of the Panvel business.
  • Cimed: Brazilian pharmaceutical manufacturer whose products (including those branded and distributed via Panvel) feature prominently in the Panvel catalog. Ecosystem participant as a key supplier rather than direct retail competitor.

Direct peers

  • Extrafarma: Brazilian pharmacy chain operating a network of physical stores and e-commerce, focusing on affordable medications and health products. Comparable omnichannel model and broad assortment approach to Panvel.
  • Nissei: Brazilian pharmacy chain with strong regional presence in Southern Brazil (Paraná, Santa Catarina), directly overlapping Panvel's core geography. Both operate multi-state pharmacy retail with comparable mix of medications, dermocosmetics, and personal care.
  • Ultrafarma: Brazilian pharmacy with strong digital presence competing on price-driven pharmacy e-commerce. Comparable product categories to Panvel with emphasis on affordable Rx/OTC delivery, representing the digital threat to Panvel's omnichannel model.
  • Drogaria Catarinense: Established pharmacy chain headquartered in Santa Catarina with deep roots across Southern Brazil. Closely comparable in regional focus, physical-store-led model, and broad assortment spanning health, beauty, and personal care.
  • Drogaria Onofre: Legacy Brazilian pharmacy chain operating physical stores and e-commerce platform. Competes with Panvel across prescription, OTC, and beauty categories with comparable horizontal assortment.

Broad incumbents

  • RD Saúde (Raia Drogasil): Brazil's largest pharmacy chain (Raia + Drogasil banners), operating over 2,800 stores nationwide. Overlaps with Panvel on core retail pharmacy offering but competes at vastly greater scale and geographic reach.
  • Pague Menos: National Brazilian pharmacy chain with operations across multiple regions. Competes with Panvel in the broad retail pharmacy category but with national scale, private-label depth, and broader geographic footprint.
  • DPSP (Drogaria São Paulo + Pacheco): Major São Paulo-focused pharmacy chain formed by the merger of Drogaria São Paulo and Drogaria Pacheco. Overlaps directly with Panvel in the São Paulo market and shares the omnichannel retail pharmacy model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights6 records

Customer concentration

Panvel social profiles

Digital presence

Panvel financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Panvel leadership team

Management profile

Number of profiles

Panvel funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Panvel M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Panvel

What does Panvel do?

Panvel Farmácias operates a multi-state Brazilian retail pharmacy chain selling prescription and OTC medications, dermocosmetics, perfumes, baby and maternity products, daily care items, wellness products, and its own Produtos Panvel private-label line through physical stores and the panvel.com e-commerce platform. The offering is extended by the Panvel Clinic service module providing vaccinations, rapid tests, pharmaceutical consultations and home care, plus the Farmácia Popular government-subsidized program and the subscription-style Programa Uso Contínuo for chronic-condition patients.

Is Panvel a public or private company?

Panvel is a private company. It is classified as corporate owned and is currently operating.

When was Panvel founded?

Panvel was founded in 1989. It employs 1,001 to 5,000 people.

Where is Panvel based?

Panvel is headquartered in São Paulo, Brazil, in the Latin America region.

How does Panvel make money?

Two revenue lines are on record. Retail Pharmacy Sales are the primary driver. The others are pharmaceutical Services.

Who are Panvel's main competitors?

Others on record are Grupo Dimed and Cimed. Direct peers are Extrafarma, Nissei, Ultrafarma, Drogaria Catarinense and Drogaria Onofre. Broad incumbents are RD Saúde (Raia Drogasil), Pague Menos and DPSP (Drogaria São Paulo + Pacheco).

Does Panvel have an API?

No public API is recorded for Panvel.

What industry is Panvel in?

Panvel's product category is Retail Pharmacy. Its primary akta.pro industry code is CRAFAFAI, Pharmacy & Health Essentials Delivery, with a secondary code of CRABAAAF, Dermocosmetics & Medical-Grade Skincare. Its NAICS code is 45611 and its SIC code is 5912.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
pegnMercado Livre starts selling prescription medication within an hourMercado Livre launched its Envios Agora program to deliver prescription medications within an hour, starting in São Paulo. The move caused major pharmacy chains' shares to fall, with Pague Menos dropping 8%. The company plans to integrate 20 pharmacies in São Paulo this year.InfoMoneyRD, Pague Menos e Panvel: farmacêuticas desabam até 8% após anúncio do Mercado LivreMercado Livre announced it will sell prescription drugs, causing pharmaceutical stocks to fall on B3. RD Saúde dropped 5.38%, Pague Menos 8%, and Panvel 4.90%. The service launches Monday, with 20 pharmacies expected by year-end.InfoMoneyCom peso de canetas emagrecedoras, Itaú BBA revê estimativas para farmáciasItaú BBA revised its estimates for three pharmacy stocks after Q2 2026 results, keeping RD Saúde's price target at R$25, cutting Pague Menos to R$5.50, and raising Panvel to R$16. The bank raised Panvel's recommendation to buy, citing momentum and attractive valuation.NeofeedConcorrência ou oportunidade? O que pensa a Panvel sobre a entrada das farmácias nos supermercadosThe CFO of Panvel, Antônio Napp, stated that the recent integration of pharmacies within supermarkets and atacarejos is not seen as a significant threat to the company, at least in the short term. He believes that the purchase of medications is usually driven by urgency rather than a shopping trip for groceries. Panvel plans to expand its physical locations to 1,000 by 2030, increasing its online sales, which currently contribute to one-third of its revenue, with expectations to exceed 50% by 2030.InfoMoneyFarmácias: balanços mostram avanço de RD e Panvel; RADL3 segue favorita de bancoBrazilian pharmaceutical retail companies on the stock exchange reported strong second quarter 2026 results, with RD Saúde and Panvel posting robust sales growth of 18% and 15% respectively, outperforming the broader market's 8.8% gain. Itaú BBA maintained RD Saúde (RADL3) as its top sector pick, citing attractive valuation with 25% upside potential and a price-to-earnings ratio of 17x for 2027. Panvel led in market share gains, advancing 4.8 percentage points, while e-commerce penetration continued growing across all players with Panvel up 34% in the period.ExameCanetas emagrecedoras turbinam vendas nas farmácias, mas não a bolsaGLP-1 weight loss medications have significantly boosted Brazilian pharmacy retailers' sales, with the market projected to grow from R$10 billion to R$50 billion by decade-end, yet stock performance has been negative, with RD Saúde down 20.43%, Pague Menos down 43.19%, and Panvel down approximately 7% year-to-date through July 2026. Eli Lilly's Mounjaro has driven the strongest results, generating R$13.54 billion in Brazil since its 2024 launch, while generic manufacturer EMS entered with 30% lower pricing, intensifying competition as patent expirations compress margins. Analysts note that while GLP-1 products increase pharmacy revenues, investors remain uncertain whether retailers can offset falling medication prices with volume growth in an informal market estimated to rival formal sales.AD HOC NEWSPanvel stock reflects recent earnings and expansion push in BrazilPanvel reported fiscal 2024 revenue of approximately BRL 5.0 billion, up about 10% from BRL 4.5 billion in fiscal 2023, while net income grew to around BRL 150 million from BRL 140 million, reflecting earnings growth despite ongoing expansion spending. The Brazilian pharmacy chain has expanded its store network to above 550 locations from roughly 520 previously, while strengthening digital channels, with operating cash flow improving to BRL 250 million from BRL 230 million. The company maintains a mid-single-digit operating margin as it balances revenue growth with margin preservation through its ongoing store opening program and logistics investments.Brazil JournalNa era do GLP-1, a Panvel — a 7x lucro — quer mostrar que é mais que issoPanvel's CEO Julio Mottin Neto defended the company's GLP-1 reliance, noting 13% of sales come from the category. The stock trades at 7x forward earnings, below the sector's 8-10x range. The company targets R$11.5-12B revenue by 2030.Brazil JournalO mercado só vê o GLP-1 – a Panvel quer mostrar que é mais do que isso - Brazil JournalPanvel, a Brazilian pharmacy chain, saw its stock surge 80% between November 2025 and March 2026 on GLP-1 drug expectations, only to decline nearly 31% from its year high as investors grew skeptical about how much GLP-1 demand will actually be captured by pharmacy chains and at what margins versus the informal market. The company is now working to convince investors it offers a broader investment thesis beyond the GLP-1 trend, amid a broader market downturn and macroeconomic headwinds affecting the sector.The Times of IndiaRaigad collector strikes down 30-acre private forest land diversion in Navi Mumbai | Mumbai News - The Times of IndiaThe Raigad district collector overturned a previous decision by a Panvel SDO allowing diversion of approximately 30 acres of private forest land in Morbe village for non-forest use, after an appeal was filed by the deputy conservator of forest. The land includes trees and streams, and was granted exemption under state law without prior approval from the Union government, which led to the cancellation of the diversion order. The reversal highlights ongoing concerns over deforestation and climate change, and the case is under review with a 90-day appeal period.